Ethnic differences in response to morphine

Only recently has attention been focused on the importance of interethnic differences as determinants of interindividual variability in drug response. We compared the pharmacokinetics and pharmacodynamics of morphine in eight Chinese and eight white healthy men after 0.15 mg/kg of morphine intravenously. The clearance of morphine was significantly higher in the Chinese subjects than in the white subjects because of an increase in the partial metabolic clearance by glucuronidation. There was no interethnic difference in the metabolism to normorphine. Morphine depressed the respiratory response to rebreathing carbon dioxide more in white subjects than in Chinese subjects, resulting in a greater reduction in resting ventilation and resting end‐tidal Pco2. The slope of the ventilation/Pco2 response curve, a measure of carbon dioxide sensitivity, was reduced more in white subjects than Chinese subjects. As a result, white subjects had a greater depression in ventilation at a Pco2 of 55 mm Hg. The morphine‐induced reduction in blood pressure was also greater in white subjects than in Chinese subjects. Thus this study has shown ethnicity to be an important determinant of the disposition and effects of morphine.

[1]  G R Wilkinson,et al.  Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. , 1989, The New England journal of medicine.

[2]  H. Thaler,et al.  The metabolite morphine‐6‐glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function , 1992, Clinical pharmacology and therapeutics.

[3]  D. Read,et al.  A clinical method for assessing the ventilatory response to carbon dioxide. , 1967, Australasian annals of medicine.

[4]  G. Wilkinson,et al.  Increased toxicity and reduced clearance of lidocaine by cimetidine. , 1982, Annals of internal medicine.

[5]  G. Wilkinson,et al.  Reduction of liver blood flow and propranolol metabolism by cimetidine. , 1981, The New England journal of medicine.

[6]  A. Adedoyin,et al.  Differing effect of atropine on heart rate in Chinese and white subjects , 1992, Clinical pharmacology and therapeutics.

[7]  R. Branch,et al.  The Influence of Cirrhosis on Steady-State Blood Concentrations of Unbound Propranolol after Oral Administration , 1978, Clinical pharmacokinetics.

[8]  A. Wood,et al.  Altered β-Adrenoceptor Internalization Does Not Explain Reduced β-Adrenergic Responsiveness in the Elderly , 1989 .

[9]  R. Branch,et al.  Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination , 1979, Clinical pharmacology and therapeutics.

[10]  Honghao Zhou,et al.  Ethnic Differences in Drug Disposition and Responsiveness , 1991, Clinical pharmacokinetics.

[11]  G. Wilkinson,et al.  Induction of propranolol metabolism by rifampicin. , 1983, British journal of clinical pharmacology.

[12]  A. Rane,et al.  Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. , 1982, Journal of chromatography.

[13]  R. Vestal,et al.  Propranolol disposition in renal failure. , 1980, British journal of clinical pharmacology.

[14]  S. Hyman,et al.  A clinical study of sensitivity to sodium nitroprusside during controlled hypotensive anesthesia in young and elderly patients. , 1986, Anesthesia and analgesia.

[15]  M. Slevin,et al.  An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites. , 1988, Journal of chromatography.

[16]  B. Monsarrat,et al.  Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. , 1992, The Journal of pharmacology and experimental therapeutics.

[17]  S. Joel,et al.  The analgesic activity of morphine-6-glucuronide. , 1992, British journal of clinical pharmacology.